Stock listing
Mezzion Pharma Co., Ltd.
Selected listing: 140410 · KRX · KRW · KR
Mezzion Pharma Co., Ltd. (KRX:140410), Health Technology. Latest release Jul 31, 2025: Mezzion Pharmaceuticals Reaches Key Enrollment Milestone in World's…
- Ticker
- KRX:140410
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- KRX
- Currency
- KRW
About Mezzion Pharma Co., Ltd.
Mezzion Pharma Co., Ltd. is a public company listed on the Korean stock market under the ticker 140410. Mezzion Pharma focuses on developing innovative pharmaceutical products to address unmet medical needs.
Latest news from Mezzion Pharma Co., Ltd.
Mezzion Pharmaceuticals Reaches Key Enrollment Milestone in World's Largest Fontan Clinical Trial
July 31, 2025
Mezzion Expands Udenafil Pipeline to ADPKD to Target Multi-Billion Dollar Kidney Disease Market
June 12, 2025
Mezzion Secures $20 Million in Strategic Funding to Advance Global Phase 3 Clinical Development of Udenafil for Fontan Patients
June 11, 2025
Research Mezzion Pharma Co., Ltd.
Mezzion Pharma Co., Ltd. company profile
View the public company page for Mezzion Pharma Co., Ltd. on 6ix.
Mezzion Pharma Co., Ltd. news
Read company news and market updates connected to Mezzion Pharma Co., Ltd..
Mezzion Pharma Co., Ltd. investor events
Find investor webinars, events, and replay context for Mezzion Pharma Co., Ltd..